| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/01/2001 | CA2378473A1 Modulation of platelet activation |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072891A2 Detection of irreversible damage to IgG antibodies |
| 01/31/2001 | EP1072682A1 Protein and gene participating in the differentiation of immortalized cells |
| 01/31/2001 | EP1072681A2 Human-keratinocytes regulator protein pKe#165 |
| 01/31/2001 | EP1072677A1 Hybridoma cell line derived from 2.4G2 cell line, preferentially not expressing any mouse kappa chains |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1072272A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071953A1 Detection and diagnosis of conditions associated with lung injury |
| 01/31/2001 | EP1071823A2 Novel mutations in the (freac3 )gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/31/2001 | EP1071788A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase |
| 01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
| 01/31/2001 | EP1071783A2 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071780A1 Soluble protein ztmpo-1 |
| 01/31/2001 | EP1071779A1 Vertebrate patched-2 protein |
| 01/31/2001 | EP1071777A2 Human nucleic acid sequences of normal uterus tissue |
| 01/31/2001 | EP1071776A2 Human nucleic acid sequences of normal bladder tissue |
| 01/31/2001 | EP1071775A2 Human nucleic acid sequences of endometrium tumour tissue |
| 01/31/2001 | EP1071774A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
| 01/31/2001 | EP1071773A1 Sh2 domain-containing peptides |
| 01/31/2001 | EP1071771A2 Gene encoding syntaxin interacting protein |
| 01/31/2001 | EP1071766A1 HUMAN G-PROTEIN COUPLED RECEPTOR GPR6sb |
| 01/31/2001 | EP1071765A1 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071758A1 Porcine adenovirus type 3 genome |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071714A1 A novel g-protein coupled receptor |
| 01/31/2001 | EP1071712A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it |
| 01/31/2001 | EP1071710A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
| 01/31/2001 | EP1071709A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 01/31/2001 | EP1071698A1 Nucleic acid sequences and proteins associated with aging |
| 01/31/2001 | EP1071694A1 Staphylococcus aureus spo0j2: polynucleotide and protein |
| 01/31/2001 | EP1071469A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor |
| 01/31/2001 | EP1071460A1 INTERNALIZING ErbB2 ANTIBODIES |
| 01/31/2001 | EP1071459A1 Methods to provoke anti-cancer immune responses |
| 01/31/2001 | EP1071458A1 Humanized antibody and uses thereof |
| 01/31/2001 | EP1071449A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 01/31/2001 | EP1071443A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 01/31/2001 | EP1071442A1 Methods and compositions for peptide synthesis |
| 01/31/2001 | EP1071400A1 Drug delivery of proteins from polymeric blends |
| 01/31/2001 | EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
| 01/31/2001 | CN1282372A Mammalian sytokine-like polypeptide-10 |
| 01/31/2001 | CN1282339A Monoclonal antibody to alpha 2-macroglobulin and its use for detecting glucan |
| 01/31/2001 | CN1282338A A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 01/31/2001 | CN1281978A Anti-alpha-fetoprotein antibody labelled by fluorescein and its preparation method |
| 01/31/2001 | CN1281898A Human zinc finger protein isomer and its code sequence |
| 01/31/2001 | CN1281897A Human thioredoxin related protein and its code sequence |
| 01/31/2001 | CN1281896A Human nuclear receptor factor protein an its code sequence |
| 01/31/2001 | CN1281895A Human mitochondrial solute carrier protein isomer and its code sequence |
| 01/30/2001 | US6180776 MTS2 gene |
| 01/30/2001 | US6180773 The cc type chemokines belong to a family of polypeptides which have proven to be mediators of immune reactions, and which have antiviral activity with respect to hiv |
| 01/30/2001 | US6180771 Given nucleotide sequence; useful for pharmaceutical administration or methods of diagnosing sensitivity to house dust mites |
| 01/30/2001 | US6180760 Of given amino acid sequence, a cdna sequence, and antibody specifically recognizing 1-afadin; 1-afadin contributes to the cell-to-cell adherens junction (aj) having a role in individual formation of animals and pathigenesis |
| 01/30/2001 | US6180406 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
| 01/30/2001 | US6180383 Insect proteolytic enzyme; for the prevention of insect infestation |
| 01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
| 01/30/2001 | US6180377 Humanized antibodies |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180369 Varicella-zoster virus antigen |
| 01/30/2001 | US6180368 Ryegrass pollen allergen |
| 01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
| 01/30/2001 | US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity |
| 01/30/2001 | US6180357 Preparation of preferential anticarcinogenic immunoglobulins; isolating tumor tissue, generating immunoglobulins, test immunoglobulins for preferential toxicity to tumor |
| 01/30/2001 | US6180341 In vitro scanning saturation mutagenesis of proteins |
| 01/30/2001 | US6180336 Labelling and selection of molecules |
| 01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180102 Monoclonal antibody to human Mx protein MxA |
| 01/30/2001 | US6180099 Method of using immunoglobulin and fiber-containing compositions for human health |
| 01/30/2001 | CA2200482C Modified radioantibody fragments for reduced renal uptake |
| 01/30/2001 | CA2132953C Monospecific polyclonal antibodies to shiga-like toxins |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/30/2001 | CA2056997C A human cytokine, interleukin-9 |
| 01/25/2001 | WO2001006252A2 Prediction of hepatic failure following hepatitis c |
| 01/25/2001 | WO2001006226A2 Methods for determining the proliferation activity of cells |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005978A1 FimH ADHESIN-BASED VACCINES |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005968A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005964A1 Inhibitor of osteoclast precursor formation |
| 01/25/2001 | WO2001005955A2 Animals comprising human hepatocellular tissue |
| 01/25/2001 | WO2001005950A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 01/25/2001 | WO2001005835A1 Inactivated vaccine against feline calicivirus disease |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005831A1 Modulation of human sodium channels in dorsal root ganglia |
| 01/25/2001 | WO2001005828A1 Novel human calcium sensitive potassium channel subunits |
| 01/25/2001 | WO2001005827A1 Fima PILUS-BASED VACCINES |